glp 1 addiction study IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target Ep. 50: More Studies Point
Description
The researchers analyzed data from a large, multi-institutional medical records database, including 73,483 adults taking GLP-1sincluding Semaglutide drugs like Ozempic & Wegovy, as well as Victoza (Liraglutide), Trulicity (Dulaglutide), or Byetta (Exenatide)and compared them with the same number of adults not taking the medications, tracking health outcomes for five years after treatment began
Understanding what causes it and how to manage symptoms helps many people successfully continue treatment
GLP-1 agonists offer metabolic and anti-inflammatory benefits, but appetite suppression may drive gut microbiome dysbiosis that offsets long-term outcomes.
Bonus: The actress reveals how hormone therapy helped reverse hair thinning during perimenopause.
Popular weight-loss platform Noom has launched Noom Med, a telehealth provider that offers Ozempic and other weight-loss medications.
